ARMC
RMD icon

American Research & Management Company’s ResMed RMD Stock Holding History

American Research & Management Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.85M Sell
13,059
-624
-5% -$142K 0.79% 38
2022
Q2 		$2.87M Sell
13,683
-950
-6% -$202K 0.74% 40
2022
Q1 		$3.55M Sell
14,633
-525
-3% -$127K 0.78% 37
2021
Q4 		$3.95M Sell
15,158
-145
-0.9% -$37.6K 0.85% 39
2021
Q3 		$4.03M Sell
15,303
-225
-1% -$61.5K 0.93% 34
2021
Q2 		$3.83M Buy
15,528
+1,606
+12% +$338K 0.87% 35
2021
Q1 		$2.7M Buy
13,922
+375
+3% +$75.2K 0.65% 46
2020
Q4 		$2.88M Sell
13,547
-165
-1% -$32.9K 0.75% 39
2020
Q3 		$2.35M Sell
13,712
-130
-0.9% -$24K 0.69% 42
2020
Q2 		$2.66M Hold
13,842
– – 0.81% 39
2020
Q1 		$2.04M Sell
13,842
-574
-4% -$91.4K 0.77% 40
2019
Q4 		$2.23M Sell
14,416
-50
-0.3% -$7.21K 0.66% 44
2019
Q3 		$1.95M Hold
14,466
– – 0.59% 46
2019
Q2 		$1.76M Sell
14,466
-49
-0.3% -$5.43K 0.53% 50
2019
Q1 		$1.51M Buy
14,515
+1,100
+8% +$114K 0.43% 57
2018
Q4 		$1.53M Sell
13,415
-200
-1% -$21.4K 0.52% 49
2018
Q3 		$1.57M Hold
13,615
– – 0.47% 54
2018
Q2 		$1.41M Buy
13,615
+130
+1% +$13.2K 0.49% 50
2018
Q1 		$1.33M Buy
13,485
+70
+0.5% +$6.62K 0.44% 51
2017
Q4 		$1.14M Buy
13,415
+400
+3% +$33K 0.35% 60
2017
Q3 		$1M Buy
13,015
+300
+2% +$22.9K 0.32% 67
2017
Q2 		$990K Buy
12,715
+1,375
+12% +$98.4K 0.33% 62
2017
Q1 		$816K Buy
11,340
+350
+3% +$24.2K 0.29% 62
2016
Q4 		$682K Buy
10,990
+5,600
+104% +$343K 0.23% 71
2016
Q3 		$349K Buy
5,390
+800
+17% +$53.3K 0.13% 89
2016
Q2 		$290K Buy
4,590
+1,650
+56% +$97.3K 0.11% 87
2016
Q1 		$170K Buy
2,940
+550
+23% +$31.1K 0.07% 108
2015
Q4 		$128K Buy
2,390
+2,010
+529% +$113K 0.05% 119
2015
Q3 		$19K Buy
+380
New +$20.5K 0.01% 237

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Research & Management Company's RMD Position: Q3 2022 in Review

American Research & Management Company reduced its ResMed (RMD) stake by 4.6% in Q3 2022, selling an estimated $142K and leaving 13,059 shares worth $2.85M. The position accounts for 0.79% of the portfolio, ranked #38.

American Research & Management Company first reported a position in RMD in Q3 2015 and has held it in 29 quarters since. The position peaked at $4.03M in Q3 2021. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • American Research & Management Company held 13,059 shares of ResMed worth $2.85M as of Q3 2022.
  • American Research & Management Company sold 624 ResMed shares in Q3 2022, an estimated $142K.
  • ResMed made up 0.79% of American Research & Management Company's portfolio in Q3 2022, its #38 holding.
  • American Research & Management Company first reported a position in ResMed in Q3 2015 and has held it in 29 quarters since.
  • American Research & Management Company's ResMed position peaked at $4.03M in Q3 2021.
  • 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.